
A nurse prepares a Covid vaccine
(Picture: PA Wire)Antibody therapies offer significant protection against Covid-19 for clinically vulnerable people, according to new research.
Analysis of data from over 24,700 patients found that prophylactic antibody therapies were 86 per cent effective in preventing death from the virus in immunocompromised patients, such as people with blood cancer or autoimmune disease.